Interferon-Gamma-Release assay and absolute CD8 lymphocyte count for acquired immunosuppression monitoring in critically ill patients
Abstract
No abstract availableKeywords
Funding Information
- Sanofi
- Agence Nationale de la Recherche (#ANR-10-AIRT-03)
- GlaxoSmithKline
This publication has 37 references indexed in Scilit:
- Sepsis Pathophysiology, Chronic Critical Illness, and Persistent Inflammation-Immunosuppression and Catabolism SyndromeCritical Care Medicine, 2017
- Incidence, Risk Factors, and Attributable Mortality of Secondary Infections in the Intensive Care Unit After Admission for SepsisJAMA, 2016
- Sepsis-induced immune dysfunction: can immune therapies reduce mortality?Journal of Clinical Investigation, 2016
- A Novel Biomarker of Immune Function and Initial Experience in a Transplant PopulationTransplantation, 2014
- Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapyNature Reviews Immunology, 2013
- Immunotherapy for the Adjunctive Treatment of Sepsis: From Immunosuppression to Immunostimulation. Time for a Paradigm Change?American Journal of Respiratory and Critical Care Medicine, 2013
- Granulocyte–Macrophage Colony-stimulating Factor to Reverse Sepsis-associated Immunosuppression: A Double-Blind, Randomized, Placebo-controlled Multicenter TrialAmerican Journal of Respiratory and Critical Care Medicine, 2009
- Successful Treatment of a Critically Ill Patient with Disseminated Coccidioidomycosis, Using Adjunctive Interferon‐γClinical Infectious Diseases, 2004
- Immunoparalysis in patients with severe trauma and the effect of inhaled interferon-γ*Critical Care Medicine, 2002
- Monocyte deactivation in septic patients: Restoration by IFN-γ treatmentNature Medicine, 1997